Jerold S. Harmatz

15.1k total citations · 1 hit paper
236 papers, 11.8k citations indexed

About

Jerold S. Harmatz is a scholar working on Pharmacology, Psychiatry and Mental health and Pharmacology. According to data from OpenAlex, Jerold S. Harmatz has authored 236 papers receiving a total of 11.8k indexed citations (citations by other indexed papers that have themselves been cited), including 78 papers in Pharmacology, 69 papers in Psychiatry and Mental health and 53 papers in Pharmacology. Recurrent topics in Jerold S. Harmatz's work include Pharmacogenetics and Drug Metabolism (71 papers), Epilepsy research and treatment (47 papers) and Anesthesia and Sedative Agents (30 papers). Jerold S. Harmatz is often cited by papers focused on Pharmacogenetics and Drug Metabolism (71 papers), Epilepsy research and treatment (47 papers) and Anesthesia and Sedative Agents (30 papers). Jerold S. Harmatz collaborates with scholars based in United States, Germany and France. Jerold S. Harmatz's co-authors include David J. Greenblatt, Richard I. Shader, Lisa L. von Moltke, Ann Locniskar, Su Duan, Marcia D. Allen, Nicholas M. P. King, Jürgen Schmider, Michael H. Court and Caroline Wright and has published in prestigious journals such as New England Journal of Medicine, American Journal of Psychiatry and Biological Psychiatry.

In The Last Decade

Jerold S. Harmatz

232 papers receiving 11.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effect of Age, Gender, and Obesity on Midazolam Kinetics

1984 402 citations David J. Greenblatt, Ann Locniskar et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jerold S. Harmatz United States	65	4.0k	2.7k	2.4k	1.7k	1.7k	236	11.8k
Edward M. Sellers Canada	73	4.0k 1.0×	3.6k 1.3×	4.9k 2.0×	3.1k 1.8×	2.0k 1.2×	423	28.5k
Richard I. Shader United States	81	5.2k 1.3×	5.5k 2.1×	4.0k 1.7×	2.9k 1.7×	2.3k 1.4×	549	21.5k
Pierre Baumann Switzerland	53	2.1k 0.5×	2.7k 1.0×	2.2k 0.9×	1.4k 0.8×	863 0.5×	322	8.7k
Meindert Danhof Netherlands	61	2.4k 0.6×	1.7k 0.6×	2.7k 1.1×	3.3k 1.9×	2.0k 1.2×	496	15.3k
Leif Bertilsson Sweden	71	8.7k 2.1×	3.8k 1.4×	3.5k 1.5×	3.1k 1.8×	3.8k 2.2×	292	17.5k
Edoardo Spina Italy	58	2.5k 0.6×	5.0k 1.9×	2.0k 0.8×	2.1k 1.2×	915 0.5×	273	9.9k
Andrew A. Somogyi Australia	50	2.1k 0.5×	727 0.3×	2.1k 0.9×	1.7k 1.0×	1.2k 0.7×	253	9.1k
Jan Koch‐Weser United States	76	1.2k 0.3×	1.4k 0.5×	2.3k 1.0×	1.5k 0.9×	750 0.4×	220	15.4k
Lisa L. von Moltke United States	62	5.0k 1.2×	903 0.3×	1.5k 0.6×	1.9k 1.1×	2.9k 1.7×	147	9.2k
Nicholas M. P. King United States	53	1.2k 0.3×	1.1k 0.4×	1.2k 0.5×	1.1k 0.7×	620 0.4×	168	8.8k

Countries citing papers authored by Jerold S. Harmatz

Since Specialization

Citations

This map shows the geographic impact of Jerold S. Harmatz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jerold S. Harmatz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jerold S. Harmatz more than expected).

Fields of papers citing papers by Jerold S. Harmatz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jerold S. Harmatz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jerold S. Harmatz. The network helps show where Jerold S. Harmatz may publish in the future.

Co-authorship network of co-authors of Jerold S. Harmatz

This figure shows the co-authorship network connecting the top 25 collaborators of Jerold S. Harmatz. A scholar is included among the top collaborators of Jerold S. Harmatz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jerold S. Harmatz. Jerold S. Harmatz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Greenblatt, David J., et al.. (2023). Estimation of Absolute and Relative Body Fat Content Using Noninvasive Surrogates: Can DXA Be Bypassed?. The Journal of Clinical Pharmacology. 63(S2). S35–S47. 1 indexed citations

Greenblatt, David J., Jerold S. Harmatz, James K. Walsh, et al.. (2011). Pharmacokinetic profile of SKP‐1041, a modified release formulation of zaleplon. Biopharmaceutics & Drug Disposition. 32(9). 489–497. 2 indexed citations

Ansell, Jack, et al.. (2009). The Absence of an Interaction Between Warfarin and Cranberry Juice: A Randomized, Double‐Blind Trial. The Journal of Clinical Pharmacology. 49(7). 824–830. 33 indexed citations

Gan, Lu, Lisa L. von Moltke, Lauren A. Trepanier, et al.. (2008). Role of NADPH-Cytochrome P450 Reductase and Cytochrome-b5/NADH-b5 Reductase in Variability of CYP3A Activity in Human Liver Microsomes. Drug Metabolism and Disposition. 37(1). 90–96. 34 indexed citations

Greenblatt, David J., Lisa L. von Moltke, Yan Luo, et al.. (2006). Ginkgo biloba Does Not Alter Clearance of Flurbiprofen, a Cytochrome P450‐2C9 Substrate. The Journal of Clinical Pharmacology. 46(2). 214–221. 48 indexed citations

Greenblatt, David J., Lisa L. von Moltke, Jerold S. Harmatz, et al.. (2003). Short‐Term Exposure to Low‐Dose Ritonavir Impairs Clearance and Enhances Adverse Effects of Trazodone. The Journal of Clinical Pharmacology. 43(4). 414–422. 48 indexed citations

Olubodun, J.O.B., Hermann R. Ochs, Lisa L. von Moltke, et al.. (2003). Pharmacokinetic properties of zolpidem in elderly and young adults: possible modulation by testosterone in men. British Journal of Clinical Pharmacology. 56(3). 297–304. 80 indexed citations

Venkatakrishnan, Karthik, Jürgen Schmider, Jerold S. Harmatz, et al.. (2001). Relative Contribution of CYP3A to Amitriptyline Clearance in Humans: In Vitro and In Vivo Studies. The Journal of Clinical Pharmacology. 41(10). 1043–1054. 49 indexed citations

Moltke, Lisa L. von, David J. Greenblatt, Jeffrey M. Grassi, et al.. (1999). Citalopram and desmethylcitalopram in vitro: human cytochromes mediating transformation, and cytochrome inhibitory effects. Biological Psychiatry. 46(6). 839–849. 75 indexed citations

10.

Moltke, Lisa L. von, David J. Greenblatt, Su Duan, Jerold S. Harmatz, & Richard I. Shader. (1998). Inhibition of Triazolam Hydroxylation by Ketoconazole, Itraconazole, Hydroxyitraconazole and Fluconazole In‐vitro. Pharmacy and Pharmacology Communications. 4(9). 443–445. 19 indexed citations

11.

Kaplan, Gary B., David J. Greenblatt, Bruce L. Ehrenberg, et al.. (1998). Single‐Dose Pharmacokinetics and Pharmacodynamics of Alprazolam in Elderly and Young Subjects. The Journal of Clinical Pharmacology. 38(1). 14–21. 28 indexed citations

12.

Moltke, Lisa L. von, David J. Greenblatt, Su Duan, et al.. (1997). Human cytochromes mediating N -demethylation of fluoxetine in vitro. Psychopharmacology. 132(4). 402–407. 70 indexed citations

13.

Scavone, Joseph M., et al.. (1997). Influence of Oral Contraceptive Use and Cigarette Smoking, Alone and Together, on Antipyrine Pharmacokinetics. The Journal of Clinical Pharmacology. 37(5). 437–441. 11 indexed citations

14.

Schmider, J., David J. Greenblatt, Lisa L. von Moltke, et al.. (1996). Characterization of Six in vitro Reactions Mediated by Human Cytochrome P450: Application to the Testing of Cytochrome P450-Directed Antibodies. Pharmacology. 52(2). 125–134. 41 indexed citations

15.

Moltke, Lisa L. von, David J. Greenblatt, Jerold S. Harmatz, & Richard I. Shader. (1993). Alprazolam Metabolism in vitro: Studies of Human, Monkey, Mouse, and Rat Liver Microsomes. Pharmacology. 47(4). 268–276. 94 indexed citations

16.

Greenblatt, David J., Joseph M. Scavone, Jerold S. Harmatz, Nina Engelhardt, & Richard I. Shader. (1993). Cognitive effects of β-adrenergic antagonists after single doses: Pharmacokinetics and pharmacodynamics of propranolol, atenolol, lorazepam, and placebo. Clinical Pharmacology & Therapeutics. 53(5). 577–584. 30 indexed citations

17.

Greenblatt, David J., et al.. (1991). Sensitivity to Triazolam in the Elderly. New England Journal of Medicine. 324(24). 1691–1698. 190 indexed citations

18.

Locniskar, Ann, David J. Greenblatt, Jerold S. Harmatz, & Richard I. Shader. (1989). Bioinequivalence of a generic brand of diazepam. Biopharmaceutics & Drug Disposition. 10(6). 597–605. 12 indexed citations

19.

Greenblatt, David J., et al.. (1988). Desmethyldiazepam Pharmacokinetics: Studies Following Intravenous and Oral Desmethyldiazepam, Oral Clorazepate, and Intravenous Diazepam. The Journal of Clinical Pharmacology. 28(9). 853–859. 34 indexed citations

20.

Belfer, Myron L., et al.. (1968). Stress and bronchitis.. BMJ. 3(5621). 805.3–806. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact